NARATRIPTAN
Generic: NARATRIPTAN
Bionpharma Inc.Manufacturer
ORALRoute
NARATRIPTAN HYDROCHLORIDEActive Substance
2012-04-30Original Approval
NARATRIPTAN is FDA application ANDA091441, sponsored by ORBION PHARMS. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Top Reported Reactions
1
DRUG INEFFECTIVE
185 reports
2
MIGRAINE
120 reports
3
NAUSEA
110 reports
4
HEADACHE
99 reports
5
FATIGUE
70 reports
6
DIZZINESS
66 reports
7
OFF LABEL USE
63 reports
8
DIARRHOEA
61 reports
9
VOMITING
60 reports
10
PAIN
52 reports